FDA NDC Directory · JSON-LD · Markdown

Lyleq

NDC 50102-300 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameNORETHINDRONE
Labeler / ManufacturerAfaxys Pharma, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA207304
Dosage form / routeTABLET · ORAL
Active ingredientsNORETHINDRONE (.35 mg/1)
Marketing started20160923
Package count1

External sources

Source: openFDA. Public-domain (CC0).